ANKARA — Physicians have launched the world’s first mRNA lung cancer vaccine trial across seven countries, including Türkiye, in a groundbreaking effort that could revolutionize cancer treatment, according to press reports on Friday.
The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.
AUCKLAND — New Zealand on Sunday reclaimed the world record for the largest mass haka after more than 6,000 people performed the legendary Maori war dance, dethroning France. The record was broken in deafening fashion […]
THREE corporations belonging to the Sy family conglomerate lead the 13 Philippine firms that made Time Magazine and Statista’s list of World’s Best Companies for 2024. SM Investments Corp. (SMIC) ranked 502nd in the list, […]
MANILA, Philippines —Krishnah Marie Gravidez was crowned Miss World Philippines 2024 early Saturday. First Princess was Jasmin Omay of Tarlac and Second Princess was Sophia Bianca Santos of Pampanga. The favorite since the start of […]
Copyright ©2024 New Babylon Group of Companies OPC
Be the first to comment